Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.

Pigment cell & melanoma research - 1 Dec 2009

Charles Julie, Templier Isabelle, Leroux Dominique, Salameire Dimitri, Robert Caroline, Lantuejoul Sylvie, Leccia Marie-Therese

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Mutational Analysis
Share to Genetic Predisposition to Disease
Share to Levodopa

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Parkinson Disease

Share to Skin Neoplasms

Share to Ultraviolet Rays

Source

Identifiers

PMID: 19708914
DOI: 10.1111/j.1755-148X.2009.00624.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.PMID 19708914Read ↗

A Review of the Association Between Parkinson Disease and Malignant Melanoma.Semantic proximity Read ↗

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.Semantic proximity Read ↗

Malignant melanoma in a woman with LEOPARD syndrome: identification of a germline PTPN11 mutation and a somatic BRAF mutation.Semantic proximity Read ↗

[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma].Semantic proximity Read ↗

Selection criteria for genetic assessment of patients with familial melanomaSemantic proximity Read ↗

Cutaneous malignant melanoma and Parkinson disease: Common pathways?Semantic proximity Read ↗

The association between Parkinson's disease and melanomaSemantic proximity Read ↗

Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegenerationSemantic proximity Read ↗

Family history of melanoma and Parkinson disease risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.